Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-methoxyphenyl)-4-aminopiperidine is a chemical compound that features a piperidine ring with an amino group at the 4th position and a 4-methoxyphenyl group attached to the 1st position. 1-(4-methoxyphenyl)-4-aminopiperidine is recognized for its potential pharmacological properties and is often utilized as a precursor in the development of new medications for a variety of applications. Its structure and activity have been extensively studied, highlighting its potential as a therapeutic agent. However, due to its potent nature, it is crucial that 1-(4-methoxyphenyl)-4-aminopiperidine is handled with care and used exclusively in a controlled laboratory environment by trained professionals.

259663-88-2

Post Buying Request

259663-88-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

259663-88-2 Usage

Uses

Used in Pharmaceutical Research:
1-(4-methoxyphenyl)-4-aminopiperidine is used as a chemical precursor for the development of new medications due to its potential pharmacological properties. Its structure and activity make it a valuable compound for creating therapeutic agents that can address various health conditions.
Used in Controlled Laboratory Settings:
As a potent chemical compound, 1-(4-methoxyphenyl)-4-aminopiperidine is used as a research tool in controlled laboratory settings by trained professionals. Its application in these environments allows for the safe exploration of its potential uses and the development of new pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 259663-88-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,9,6,6 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 259663-88:
(8*2)+(7*5)+(6*9)+(5*6)+(4*6)+(3*3)+(2*8)+(1*8)=192
192 % 10 = 2
So 259663-88-2 is a valid CAS Registry Number.

259663-88-2Relevant academic research and scientific papers

Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative

-

, (2008/06/13)

The present invention provides a method of treatment of a disease associated with neurodegeneration by administering a therapeutically effective amount of a compound of the general formula whereinAr1 is phenyl, naphthyl or tetrahydronaphthyl, optionally substituted by hydroxy, lower alkoxy, nitro, amino or methanesulfonamide;Ar2 is phenyl, naphthyl or tetrahydronaphthyl, optionally substituted by lower alkyl or halogen;X is C, CH, C(OH) or N;Y is —CH2?, CH or O;Z —CH2—, —CH(CH3)— or —C(CH3)2—;R1 is hydrogen, lower alkyl or acetyl;A is C=O or —(CHR2)n—, wherein R2 is hydrogen, lower alkyl or hydroxy-lower alkyl;B is —(CH2)n—, O, —CH(OH)(CH2)n—, —CH(CH2OH)(CH2)n—, —(CH2)n CH(OH)— or —CH(CH2OH)—;- - - may be a bond; andn is 0-4,or pharmaceutically acceptable acid addition salts thereof.

Stepwise versus direct long-range charge separation in molecular triads

Willemse,Piet,Warman,Hartl,Verhoeven,Brouwer

, p. 3721 - 3730 (2007/10/03)

Trifunctional electron donor - donor - acceptor molecules are described in which photoinduced charge separation, D2 - D1 - A* → D2 - D1+ - A- , is followed by a charge migration step D

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 259663-88-2